Andrei A Bunaciu*

Department of Infrared Spectroscopy, Bunaciu Andrei P.F.A, (S.E.P..), Bragadiru – Ilfov district, 077025, Romania

*Corresponding Author: Andrei A Bunaciu, Department of Infrared Spectroscopy, Bunaciu Andrei P.F.A, (S.E.P..), Bragadiru – Ilfov district, 077025, Romania.

Received: September 18, 2026; Published: October 14, 2026

Although infrared spectroscopy has long been used to describe chemical molecules, its applicability to the analysis of biological materials containing very complex chemical components is questionable. Recent advancements have significantly increased infrared spectroscopy’s capacity to examine various biological materials. As a result, more research is being done with infrared spectroscopy for disease screening and diagnosis. By identifying biochemical alterations in cancer patients, Fourier transform infrared spectroscopy has the potential to enhance clinical decision-making and patient outcomes because it is more straightforward, quick, accurate, affordable, non-destructive, and automated than current screening, diagnosis, management, and monitoring techniques. By accurately identifying the molecular conformations, bonding types, functional groups, and intermolecular interactions that make up the specimen, FTIR spectroscopy can determine biochemical compositions inside biological materials, such as nucleic acids, proteins, lipids, and carbohydrates. IR spectroscopy creates a distinctive spectral fingerprint of absorbance peaks for various characteristics of the genome, lipidome, proteome, and metabolome in the sample under study, since every molecule has a different spectrum based on the wavelength and amount of infrared light being absorbed.

Keywords: Infrared Spectroscopy; Biomedical Analysis; Cancer Diagnostic; Treatment Monitoring

References

1. (WHO) WHO. Cancer (2026).
2. Sawyers C. “Targeted cancer therapy”. Nature7015 (2004): 294-297.
3. Schiffman JD., et al. “Early Detection of Cancer: Past, Present, and Future”. American Society of Clinical Oncology Educational Book 35 (2015): 57-65.
4. Bunaciu AA., et al. “Vibrational spectroscopy applications in biomedical, pharmaceutical and food sciences”. Elsevier; (2020).
5. Bunaciu AA and Aboul-Enein HY. “Advancements in Early Disease Diagnosis Using FTIR Spectroscopy of Body Fluid”. Achievements and Challenges of Medicine and Medical Science 13 (2025): 43-69.
6. Wen J., et al. “Advances in far-infrared research: Therapeutic mechanisms of disease and application in cancer detection”. Lasers in Medical Science 1 (2024): 41.
7. Zhang S., et al. “Molecular fingerprint detection using Raman and infrared spectroscopy technologies for cancer detection: a progress review”. Biosensors 5 (2023): 557.
8. Su K-Y and Lee W-L. “Fourier transform infrared spectroscopy as a cancer screening and diagnostic tool: A review and prospects”. Cancers1 (2020): 115.
9. Mashekova A., et al. “Early detection of the breast cancer using infrared technology–A comprehensive review”. Thermal Science Engineering Progress 27 (2022): 101142.
10. Delrue C., et al. “Unlocking the diagnostic potential of saliva: A comprehensive review of infrared spectroscopy and its applications in salivary analysis”. 13.6 (2023): 907.
11. Bunaciu AA and Aboul-Enein HY. “Early diseases diagnosis in body fluids (serum and saliva) using infrared spectroscopy”. Applied Chemical Engineering2 (2023): 2097.
12. Mererid Evans SHH., et al. “AJCC Cancer Staging System: Oropharynx (HPV-Associated): Version 9 of the AJCC Cancer Staging System. (Editor) EA, editor (2025).
13. Society AC. “Bladder statistics”. (2026).
14. Burke DM., et al. “The community-based morbidity of flexible cystoscopy”. BJU International 89 (2002): 347-349.
15. Sarkees E., et al. “Evaluation of the diagnostic potential of Fourier transform-infrared spectroscopy on urine for urothelial bladder cancer: an in-hospital field study”. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 339 (2025): 126274.
16. Neuzillet Y., et al. “French AFU Cancer Committee Guidelines - Update 2022-2024: Non-muscle-invasive bladder cancer (NMIBC)”. Progrès en Urologie 15 (2022): 1102-1140.
17. Castro-Olvera G., et al. “A review of label-free photonics-based techniques for cancer detection in the digestive and urinary systems”. Journal of Physics: Photonics1 (2025): 012002.
18. Córdova-Manzo J., et al. “Near‐Infrared Spectroscopy for Noninvasive Bladder Evaluation: Systematic Review and Future Directions”. Journal of Sensors1 (2025): 6494580.
19. Bashkami A., et al. “A review of Artificial Intelligence methods in bladder cancer: segmentation, classification, and detection”. Artificial Intelligence Review12 (2024): 339.
20. da SILVA SMSD., et al. “Optical tools for early diagnosis purposes-literature review of ft-ir spectroscopy applications”. Oral Medicine, Oral Pathology, Radiology6 (2024): e313.
21. Vander Stichele A and Van Cleynenbreugel B. “Optical Spectroscopy and Spectral Imaging for Bladder Cancer Detection and Characterisation: A Scoping Review of Diagnostic Evidence and Translational Readiness”. Diagnostics (Basel)16 (2026): 2561.
22. Kim J., et al. “Advancing bladder health diagnostics: the potential of optical techniques for noninvasive assessment of lower urinary tract disorders”. International Neurourology Journal 2 (2025): 59.
23. Oudahmane I., et al. “To what extent does freezing impact the mid-infrared signature of urine? Case of patients attending urology department”. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 309 (2024): 123820.
24. Yim A., et al. “Near‐infrared spectroscopy as a novel method of ex vivo bladder cancer tissue characterisation”. BJU International 133 (2024): 44-52.
25. Kondepati VR., et al. “Recent applications of near-infrared spectroscopy in cancer diagnosis and therapy”. Analytical and Bioanalytical Chemistry1 (2008): 125-139.
26. Hands JR., et al. “Investigating the rapid diagnosis of gliomas from serum samples using infrared spectroscopy and cytokine and angiogenesis factors”. Analytical and Bioanalytical Chemistry23 (2013): 7347-7355.
27. Theakstone AG., et al. “Investigating centrifugal filtration of serum-based FTIR spectroscopy for the stratification of brain tumours”. PLoS One 2 (2023): e0279669.
28. Burström G., et al. “Optical methods for brain tumor detection: A systematic review”. Journal of Clinical Medicine 9 (2024): 2676.
29. Leone A., et al. “Preoperative mapping techniques for brain tumor surgery: a systematic review”. Frontiers in Oncology 14 (2025): 1481430.
30. Ijaz M., et al. “Diagnostics of brain tumor in the early stage: current status and future perspectives”. Biomaterials Science10 (2025): 2580-605.
31. Mekler S., et al. “Self-and informant-reported cognitive concerns associated with primary brain tumour: systematic review”. Supportive Care in Cancer 4 (2025): 310.
32. Ghorbian M., et al. “Advancements in machine learning for brain tumor classification and diagnosis: a comprehensive review of challenges and future directions”. Archives of Computational Methods in Engineering1 (2026): 1373-408.
33. Choudhary VK., et al. “A Comprehensive Review on Artificial Intelligence for Human Brain Disease 2025”. International Conference on Inventive Computation Technologies (ICICT); IEEE (2025).
34. Mainiero MB., et al. “ACR Appropriateness Criteria Breast Cancer Screening”. Journal of the American College of Radiology11 (2016): R45-R9.
35. Tomas RC., et al. “Detection of breast cancer by ATR-FTIR spectroscopy using artificial neural networks”. PLoS One1 (2022): e0262489.
36. de Andrade Marques L., et al. “Comparative spectral analysis of blood and saliva in breast cancer, benign breast disease and healthy controls using ATR-FTIR”. Scientific Reports 16.1 (2026): 9121.
37. Faria RA., et al. “Potential Role of Fourier Transform Infrared Spectroscopy as a Screening Approach for Breast Cancer”. Applied Spectroscopy4 (2023): 405-17.
38. Anagaw YK., et al. “Application of Fourier transform infrared spectroscopy on Breast cancer diagnosis combined with multiple algorithms: A systematic review.” Photodiagnosis and Photodynamic Therapy 53 (2025): 104579.
39. Mathur P., et al. “A review on breast cancer diagnostic techniques”. Sensors Diagnostics (Basel)7 (2025): 555-573.
40. Nakul M., et al. “Machine learning enhanced optical spectroscopy for breast cancer diagnosis: A review”. Lasers in Medical Science1 (2026): 86.
41. Makhnevych I., et al. “Dynamics in quality of life of breast cancer patients following surgery: systematic review and meta-analysis”. Cancers19 (2025): 3108.
42. Tayeb BA., et al. “Liquid biopsy biomarkers in breast cancer: an overview of systematic reviews”. Clinica Chimica Acta 566 (2025): 120063.
43. Mashekova A., et al. “Review of artificial intelligence techniques for breast cancer detection with different modalities: Mammography, ultrasound, and thermography images”. Bioengineering10 (2025): 1110.
44. Institute NC. “Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®)–Health Professional Version” (2025).
45. Kowal A., et al. “Serum Fourier-Transform Infrared Spectroscopy with Machine Learning for Screening of Pediatric Acute Lymphoblastic Leukemia: A Proof-of-Concept Study”. Cancers21 (2025): 3548.
46. Nikhitha M., et al. “Pediatric Leukemia: Advances in Diagnosis and Treatment Strategies”. Journal of Pediatrics and Congenital Disorders 11 (2025): 1.
47. Ramalingam S., et al. “Anti-proliferative potential of extracellular beta-glucans isolated from Trametes hirsuta in carcinoma and leukemic cell lines”. International Journal of Biological Macromolecules 304 (2025): 140644.
48. Liu G., et al. “Systematic review and meta-analysis of the impact of abnormal expression of long non coding RNA on the prognosis of acute myeloid leukemia”. Frontiers in Genetics 16 (2025): 1524449.
49. Bray F., et al. “Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries”. CA Cancer Journal of Clinics 3 (2024): 229-263.
50. Byrne HJ., et al. “Spectropathology for the next generation: Quo vadis?” Analyst7 (2015): 2066-2073.
51. Baker MJ., et al. “Using Fourier transform IR spectroscopy to analyze biological materials”. Nature Protocols8 (2014): 1771-1791.
52. Giamougiannis P., et al. “Detection of ovarian cancer (± neo-adjuvant chemotherapy effects) via ATR-FTIR spectroscopy: comparative analysis of blood and urine biofluids in a large patient cohort”. Analytical and Bioanalytical Chemistry20 (2021): 5095-5107.
53. Phillip A., et al. “Emerging Near-Infrared Targeted Imaging Pharmaceutics for Ovarian Cancer”. Pharmaceutics5 (2026): 574.
54. Schiemer R., et al. “Infrared and Raman spectroscopy of blood plasma for rapid endometrial cancer detection: Clinical studies”. British Journal of Cancer2 (2025): 194-207.
55. Saman S., et al. “A comprehensive review on current treatments and challenges involved in the treatment of ovarian cancer”. Current Cancer Drug Targets2 (2024): 142-66.
56. Adhab HG., et al. “Use of the FTIR Technique As A Diagnostic And Monitoring Tool For Cancer Patients: A Review Of A Decade (2010–2022)”. Maaen Journal for Medical Sciences1 (2024): 6.
57. Asadi F., et al. “Comparing the effectiveness of artificial intelligence models in predicting ovarian cancer survival: a systematic review”. Cancer Reports3 (2025): e70138.
58. Wallace TA., et al. “Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale”. Carcinogenesis 8 (2011): 1107-1121.
59. Guo S., et al. “Fast and deep diagnosis using blood-based ATR-FTIR spectroscopy for digestive tract cancers”. Biomolecules12 (2022): 1815.
60. Yap XL., et al. “Detection of Prostate Cancer via IR Spectroscopic Analysis of Urinary Extracellular Vesicles: A Pilot Study”. Membranes (Basel)8 (2021).
61. Malins DC., et al. “Models of DNA structure achieve almost perfect discrimination between normal prostate, benign prostatic hyperplasia (BPH), and adenocarcinoma and have a high potential for predicting BPH and prostate cancer”. Proceedings of the National Academy of Sciences of the United States of America1 (1997): 259-264.
62. Wong L-W., et al. “Revolutionizing prostate cancer screening: Machine learning-driven FTIR analysis of biofluidic EVs integrated with clinical profiles”. Health Technology in Cancer Research Treatment3 (2025): 563-576.

Citation

Citation: Andrei A Bunaciu. “Ftir Spectroscopy Used in Cancer Diagnostics". Acta Scientific Medical Sciences 10.11 (2026): 27-39.

Copyright

Copyright: © 2026 Andrei A Bunaciu. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.